Skip to main content
Premium Trial:

Request an Annual Quote

Expression Pathology and Flagship Biosciences Partner on Protein Biomarker Work in FFPE Tissue


Proteomics firm Expression Pathology this week announced a service partnership with digital pathology company Flagship Biosciences for protein biomarker development using formalin-fixed, paraffin-embedded tissue.

The deal combines Expression Pathology's abilities in mass spec-based assays for FFPE tissue with Flagship's pathology expertise, allowing the partners to identify tissue features or sub-anatomic organelles of research interest and then extract and prep them for proteomic analysis.

Expression Pathology uses its Director laser microdissection platform to collect specific cell types from FFPE tissue. It then applies its Liquid Tissue technology to solubilize and capture the protein content of the tissue, which it then analyzes via single-reaction monitoring mass spectrometry.

The company, which, according to its website, is in the process of establishing a CLIA-certified laboratory from which it plans to provide proprietary diagnostic tests developed on its platform, offers a number of SRM assays, including several for major cancer signaling networks like EFGR, IGF-1R, cMET, Her3, cSRC, and MEK.

Last December, Expression Pathology began a collaboration with Thermo Fisher Scientific's BRIMS Center to use its FFPE sample prep to extract proteins for single-reaction monitoring assays aimed at developing cancer biomarkers (PM 12/18/2009). In May, it announced it was working with several Toronto-area hospitals to develop an assay for identifying patients most likely to respond to anti-epidermal growth factor receptor drugs (PM 05/07/2010).

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.